Medicine and Dentistry
COVID-19
100%
Cardiovascular Disease
55%
Cardiovascular System
51%
Physical Activity
50%
Randomized Controlled Trial
50%
Older Adult
50%
Middle Age
50%
Patient
28%
microRNA
25%
Biological Marker
25%
Assessment
23%
Pregnancy
21%
Heart Injury
16%
Health Outcomes
14%
Child
14%
Cardiovascular Physiology
13%
Sleep
13%
Arterial Stiffness
13%
Infection
12%
Organ Culture
12%
Wellbeing
11%
Clinician
10%
Malignant Neoplasm
10%
Diastolic Function
9%
Systolic Function
9%
Lung
9%
Cancer Treatment
8%
Development
8%
Tissues
7%
Obstetrics
7%
Diseases
7%
Clinical Assessment
7%
Cardiovascular Injury
7%
Therapeutic Procedure
7%
Combination Therapy
7%
First Trimester Pregnancy
7%
Pharmacology, Toxicology and Pharmaceutical Science
Sunitinib
95%
Biological Marker
71%
microRNA
66%
Mitogenic Agent
66%
Cardiovascular Disease
53%
Phosphotransferase
50%
Ovary Polycystic Disease
37%
Messenger RNA
32%
Protein Kinase
29%
Apoptosis Signal Regulating Kinase 1
18%
Survival Rate
17%
Prognosis
17%
Cardiotoxicity
15%
Protein Kinase C
12%
Heart Injury
12%
Infarction
10%
Long Term Survival
10%
Thromboxane Receptor
8%
Thromboxane A2
8%
Diseases
7%
Hematologic Malignancy
7%
Troponin
7%
Malignant Neoplasm
5%
Sprague Dawley Rat
5%
Anticarcinogen
5%
Western Blot
5%